Vulnerable plaque

SHL Telemedicine's SmartHeart® Technology Shows Remarkable Effects in Mayo Clinic and Imperial College London Trials

Retrieved on: 
Tuesday, September 26, 2023
Health Technology, Telemedicine, Virtual Medicine, Data Management, Other Health, Technology, Apps, Applications, Managed Care, Biometrics, Medical Devices, Hospitals, Clinical Trials, Other Technology, Cardiology, Telecommunications, Biotechnology, Health, SHL, Telehealth, Mayo Clinic, VPM, ECG, Plaque, Vulnerable plaque, Patient, Imperial College London, Clinical professor, FDA, Pharmaceutical industry

Key highlights from the presentation of the initial results include:

Key Points: 
  • Key highlights from the presentation of the initial results include:
    A staggering decrease of- 27.5% in emergency room visits in the TELE-ACS trial1.
  • Erez Nachtomy, CEO of SHL Telemedicine, commented, "The initial results from the HELP-MI and TELE-ACS trials have surpassed our expectations.
  • We are extremely confident in the potential of our SmartHeart® technology, and these findings further validate its efficacy in post-MI patient care.
  • We are looking forward to the continued positive impact our technology will have on telemedicine and remote patient care."

Tiny Bubbles Help Doctors Predict Risk of Heart Attack and Stroke

Retrieved on: 
Thursday, September 5, 2019
Research, Medical devices, Cardiology, Radiology, Health, General Health, Science, RTT, Circulatory system, Cardiovascular system, Organ systems, Vulnerable plaque, Coronary artery disease, Stroke, Heart, Myocardial infarction, Carotid artery stenosis

Doctors are using tiny microscopic bubbles to help them predict whether patients are at risk for a heart attack or stroke.

Key Points: 
  • Doctors are using tiny microscopic bubbles to help them predict whether patients are at risk for a heart attack or stroke.
  • These gas-filled bubbles, known as ultrasound contrast agents or enhancement agents, can help doctors detect vulnerable plaque in the carotid arteries leading to the brain, according to findings of a study involving 459 patients at Queens University in Kingston, Ontario (Canada).
  • Most heart attacks and strokes are likely caused by vulnerable plaque, explained Dr. Amer Johri, who spoke about the study.
  • This study shows that a simple, minimally-invasive CEUS scan can effectively help doctors predict serious and complex coronary artery disease and stratify risk of future heart attacks and strokes, Dr. Feinstein said.